Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria (Plasmodium Falciparum)”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01988636
What this trial is testing

Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 296
Early research (Phase 1)Study completedNCT02737007
What this trial is testing

A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607

Who this might be right for
Malaria, Falciparum
GlaxoSmithKline 6
Large-scale testing (Phase 3)Study completedNCT01838902
What this trial is testing

Primaquine's Gametocytocidal Efficacy in Malaria Asymptomatic Carriers

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 467
Testing effectiveness (Phase 2)Study completedNCT00360230
What this trial is testing

Partially-blind (Observer-blind) Study of Safety and Immunogenicity of Two Malaria Vaccines in Ghanaian Children

Who this might be right for
Malaria
GlaxoSmithKline 540
Large-scale testing (Phase 3)Study completedNCT00142246
What this trial is testing

Study of the Impact of Intermittent Preventive Treatment in Schools on Malaria, Anaemia and Education.

Who this might be right for
Malaria, Falciparum
London School of Hygiene and Tropical Medicine 6,758
Post-approval studies (Phase 4)Study completedNCT01755559
What this trial is testing

Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi Niger

Who this might be right for
Malaria
Epicentre 663
Not applicableStudy completedNCT00509015
What this trial is testing

Mass-Drug Administration to Reduce Malaria Transmission

Who this might be right for
Malaria, Falciparum
Radboud University Medical Center 6,000
Not applicableStudy completedNCT00479206
What this trial is testing

Artemisinin Resistance in Cambodia

Who this might be right for
Malaria, Falciparum
Medical University of Vienna
Early research (Phase 1)Ended earlyNCT00126971
What this trial is testing

Chlorproguanil-Dapsone in Pregnant Women

Who this might be right for
Malaria
Centers for Disease Control and Prevention 132
Not applicableStudy completedNCT00493363
What this trial is testing

Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia

Who this might be right for
Falciparum Malaria
University of Oxford 40
Early research (Phase 1)Ended earlyNCT04271306
What this trial is testing

Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania.

Who this might be right for
Malaria,Falciparum
University of Oxford 34
Not applicableStudy completedNCT00203736
What this trial is testing

A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria

Who this might be right for
Malaria
University of Cape Town 240
Early research (Phase 1)Study completedNCT02115516
What this trial is testing

Safety and Protective Efficacy of Intravenous Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chemoprophylaxis

Who this might be right for
MalariaPlasmodium Falciparum Malaria
Sanaria Inc. 67
Early research (Phase 1)Study completedNCT00587249
What this trial is testing

ICC-1132 - Candidate Vaccine Against P Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 75
Testing effectiveness (Phase 2)Study completedNCT02044198
What this trial is testing

A Phase I/IIa Study of the Safety, Immunogenicity and Efficacy of FMP2.1/AS01B, an Asexual Blood-Stage Vaccine for Plasmodium Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 30
Large-scale testing (Phase 3)Study completedNCT00701961
What this trial is testing

Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnancy

Who this might be right for
Plasmodium Falciparum Malaria
Institute of Tropical Medicine, Belgium 48
Not applicableUnknownNCT04695886
What this trial is testing

Effectiveness of a Community-delivered Integrated Malaria Elimination (CIME) Model in Myanmar

Who this might be right for
Malaria
Macfarlane Burnet Institute for Medical Research and Public Health Ltd 6,440
Early research (Phase 1)Study completedNCT02458092
What this trial is testing

Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B

Who this might be right for
Malaria
U.S. Army Medical Research and Development Command 30
Post-approval studies (Phase 4)Study completedNCT03241901
What this trial is testing

"Prolonging the Therapeutic Life Span of Artemisinin-based Combination Therapies (ACT) in Bagamoyo District, Tanzania"

Who this might be right for
Malaria,Falciparum
Muhimbili University of Health and Allied Sciences 280
Testing effectiveness (Phase 2)Study completedNCT02836002
What this trial is testing

Controlled Human Malaria Infection Model for Evaluation of Transmission-Blocking Interventions - Study 1

Who this might be right for
Malaria
Radboud University Medical Center 29
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation